is the fda stopping the sale of tirzepatide says weight-loss drug shortage over US judge sides with FDA's

The FDA has warned that some compounded products may contain salt forms such as semaglutide sodium or semaglutide acetate, which are different active ingredients than those in FDA-approved medications

This update comes after ongoing dialogue with the FDA, and substantial efforts by Novo Nordisk to increase manufacturing capacity, including $6.5 billion of investments in the U.S

If a provider doesnt bring up gallbladder-related risks, here are some signs that you should: A history of gallstones or gallbladder disease Previous pancreatitis Rapid weight loss in the past, such as due to weight loss surgery Family history of gallstones Being overweight or experiencing obesity Being biologically female What to Do If Symptoms Appear If any symptoms associated with gallbladder problems appear, contact a primary care provider or gastroenterologist

June 2025: A 2025 study published in JAMA Ophthalmology has found a connection between taking tirzepatide drugs like Mounjaro and developing NAION

Measure the total volume in the vial (if possible, by drawing it all out with a syringe, noting the volume, and injecting it back)

Yet, though this is promising, active trials are still ongoing